June 19, 2017
A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on June 11, 2017 with the following Interim Recommendation made:
- minoxidil, when sold in preparations for topical use in adults in concentrations of 5% or less, be granted unscheduled status, for human use only
Any objections to this Interim Recommendation must be received by the NAPRA office by July 19, 2017.
Questions or comments should be directed to the Acting Manager, Professional and Regulatory Affairs via email at email@example.com.